USPTO Deadlines
Next Deadline
967 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2022-06-21)
Due Date
June 21, 2028
Grace Period Ends
December 21, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
32 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 4, 2025 | ADCH | M | CHANGE OF NAME/ADDRESS REC'D FROM IB | Loading... |
| Mar 1, 2024 | CHLD | M | CHANGE OF OWNER RECEIVED FROM IB | Loading... |
| Oct 25, 2022 | FINV | P | FINAL DECISION TRANSACTION PROCESSED BY IB | Loading... |
| Oct 5, 2022 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB | Loading... |
| Oct 5, 2022 | FIMP | P | FINAL DISPOSITION PROCESSED | Loading... |
| Sep 21, 2022 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
| Jun 21, 2022 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Jun 21, 2022 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Apr 5, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Apr 5, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Mar 16, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Mar 8, 2022 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
| Feb 28, 2022 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Feb 25, 2022 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Feb 21, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Feb 21, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Feb 21, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Feb 14, 2022 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
| Feb 14, 2022 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
| Jan 28, 2022 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Jan 28, 2022 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jan 28, 2022 | ECDR | I | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | Loading... |
| Jan 28, 2022 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Jan 28, 2022 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Jan 28, 2022 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Jan 25, 2022 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| Jan 24, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jan 21, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Nov 6, 2021 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Nov 2, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Oct 30, 2021 | LIMI | I | LIMITATION FROM ORIGINAL APPLICATION ENTERED | Loading... |
| Oct 22, 2021 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 005
Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
Additional Information
Design Mark
The mark consists of three connected partial ovals with the top left oval in yellow, the top right oval in dark pink and the bottom oval in light pink.
Color Claim
The color(s) yellow, dark pink and light pink is/are claimed as a feature of the mark.
Classification
International Classes
005